Sanger Sequencing Market Synopsis<\/p>\n
Sanger Sequencing Market Size Was Valued at USD 2.8 Billion in 2023, and is Projected to Reach USD 12.9 Billion by 2032, Growing at a CAGR of 18.5% From 2024-2032.<\/p>\n
Sanger sequence or known as chain termination method is one of the most common sequencing methods that adopted by Frederick Sanger in 1977. This one uses identity dideoxynucleotides coupled to the DNA replication process in order to sequence nucleotides. The market for Sanger sequencing is all the machinery and equipment used in the creation and implementation of Sanger sequencing as well as all the chemicals, reagents, and consumables which are associated with Sanger sequencing. A key step in genomics and associated diagnostics, Sanger sequencing is used in several branches of application, including in personalised medicine, genetic diagnostics\/phylogenetic, and biotechnology to buttress agriculture.<\/p>\n
The market of Sanger sequencing has been growing steadily over the last few decades, with expanded need for genetic diagnostics and development of new sequencing approaches. However, because of high specificity and reproducibility Sanger sequencing has been used for confirmation of NGS data sets or for sequencing shorter fragments of DNA. The market drivers are the rising trend of genetic disorders, emphasis on the customized medicine, and the need of large-scale genomically oriented study in research center. In addition, the increasing number of investments associated with the biotechnology and pharmaceutical industries continue to enhance the need for Sanger sequencing solutions as a scientific method of analysis.<\/p>\n
Recently, added value in the field of sequencing platforms also helped the Sanger sequencing market to grow. Technological advancement in automated sequencing systems, and advanced bioinformatics tools are enhancing the aspect of sequencing. This evolution is making academic institutions, hospitals, and research organizations fund Sanger sequencing technologies, which in return are gaining wider use in clinical diagnostics and research applications. Also, Sanger sequencing when coupled with other technologies like CRISPR and NGS has made facetted opportunities in the market, thus driving growth. Therefore, the Global Sanger sequencing market is expected to grow at a higher CAGR in the foreseeable future due to developments in genetic study as well as therapeutic sectors.<\/p>\n
Sanger Sequencing Market Trend Analysis<\/p>\n
Increasing Demand for Genomic Research<\/p>\n
One major trend observable in the market is the focus on genes and genomics in the Sanger sequencing market. With researchers aspiring to seamlessly read the human map of genes and genes, which cause diseases, high accuracy processes have become vital. This trend is attributable to the revolution in the science of genomics or customized medication, where therapy is going to be provided depending on the patient\u2019s information including genetic makeup. Also, the rise in the incidences of genetic disorders and the need for correct diagnosis are some of the drivers expected to help drive the Sanger sequencing market forward. Researchers and clinicians are finding that Sanger sequencing is a valuable resource that is used more often to confirm identification accuracies of next-generation sequencing and genetic analysis. This trend brings out the necessity of Sanger sequencing in the discovery of genetics and its relevance in the diagnosis and treatment of diseases as well as in research.<\/p>\n
Expansion in Emerging Markets<\/p>\n
They also pointed out a current sizable market and high potential for expansion, especially in newly industrialized countries, in the area of Sanger sequencing. When Asian, African and Latin American countries pour resources onto health care systems and on biotechnology research, the call for sophisticated genomic systems is likely to follow. Such regions are experiencing a rising interest in hereditary disease, infectious diseases, and agro-genetic agricultural improvements. The fact that better sequence generators have emerged and developed nations are opening up their collaborations to developing nations constitute the best prospect for the vendors. Additionally, in the future, there are likely to be growth in the Sanger sequencing services resulting from the improvement in the regulatory climates for genetic tests. Big business players who sit correctly on the growth opportunity in the emerging markets could help to bare this promise and push the frontier in genomics and personal medicine forward.<\/p>\n
Sanger Sequencing Market Segment Analysis:<\/p>\n
Sanger Sequencing Market Segmented on the basis of type, application and end user. <\/p>\n
By Type, Shotgun Sequencing segment is expected to dominate the market during the forecast period<\/p>\n
Out of the two segments analyzed for the Sanger sequencing market, the Shotgun Sequencing segment is expected to hold the largest market share during the forecast period because it provides scalable results in terms of sequence data yield. This technique implies that DNA sample is fragmented randomly and is sequenced individually and then reassembled by computer programs. Whole Genome Shotgun sequencing method has gained favor in a number of applications such as whole genome sequencing, metagenomics and environmental genomics where a broad picture of genomes is required. Thanks to its capability to generate vast sequences at a short time, it suits researchers who want to investigate intricate genomes or microorganisms. <\/p>\n
Furthermore, the knowledge of the bioinformatics tools and other computational algorithms has enhanced the efficiency of data assembly latest of which makes Shotgun Sequencing more promising. Within the structure of developments in the niche, the increased perception of the advantages of this approach by research institutions and biotech companies involved in large-scale genomic projects will result in the realisation of further growth of the Sanger sequencing market due to the focus on the Shotgun sequencing segment throughout the period of the forecast.<\/p>\n
By Application, Diagnostics segment expected to held the largest share <\/p>\n
The Diagnostics segment is predicted to dominate the Sanger sequencing market in the given time period due to the advancement in genetic testing in the clinical laboratories. It is greatly used for diagnosing different genetic diseases, infective diseases, and cancer, by directing treatment according to the genetic profile of an individual. The increase in diseases with a hereditary background and the tendency to individualized medicine contribute to the need for better diagnostic devices that provide accurate results. <\/p>\n
Furthermore, Sanger sequencing is often employed to validate secondary results of other higher through-put technologies like Next Generation Sequencing (NGS) making Sanger sequencing an integral part of genomic diagnostics. Also, more development in the sequencing technologies and understanding of genomics are gradually leading Sanger sequencing into becoming an accepted tool in diagnostic laboratories making the application the market leader. Because the Diagnostics segment focuses on genetic information utilized in the clinical decision-making process, this segment will grow extensively and highly contribute to increasing its market share in the forthcoming years.<\/p>\n
Sanger Sequencing Market Regional Insights: <\/p>\n
North America is Expected to Dominate the Market Over the Forecast period <\/p>\n
According to the analysis, the North American region would be the largest market with projected market share of approximately 45% throughout the year 2023. The leadership with regard to this region may be explained by the fact that the region boasted of improved health care facilities; it is documented that genomic research received a massive boost and that biotechnology industries are well developed in the region. The United States, for instance, has a host of prominent database generating research institutions, pharmaceutical makers and biotechnology companies that are increasingly focusing stakeholders in genomics and diagnostic technologies. Furthermore, there is a large incidence of genetic disorders and rising need for technologically advanced other sequencing techniques within North America specifically in the Sanger sequencing market. This dominance is expected to persist, especially given advancements made in the sequencing technologies as well as a shift towards more genomic based studies to strengthen the regions position in the global market.<\/p>\n
Active Key Players in the Sanger Sequencing Market <\/p>\n
Agilent Technologies, Inc. (USA)<\/p>\n
BGI Group (China)<\/p>\n
Bio-Rad Laboratories, Inc. (USA)<\/p>\n
Eurofins Scientific (Luxembourg)<\/p>\n
F. Hoffmann-La Roche AG (Switzerland)<\/p>\n
Genewiz, Inc. (USA)<\/p>\n
GENEWIZ, Inc. (USA)<\/p>\n
Genomatix Software GmbH (Germany)<\/p>\n
Illumina, Inc. (USA)<\/p>\n
LGC Limited (UK)<\/p>\n
PerkinElmer, Inc. (USA)<\/p>\n
QIAGEN N.V. (Netherlands)<\/p>\n
Roche Holding AG (Switzerland)<\/p>\n
Takara Bio Inc. (Japan)<\/p>\n
Thermo Fisher Scientific (USA) Other key Players<\/p>\n","protected":false},"excerpt":{"rendered":"
Sanger sequence or known as chain termination method is one of the most common sequencing methods that adopted by Frederick Sanger in 1977. This one uses identity dideoxynucleotides coupled to the DNA replication process in order to sequence nucleotides. The market for Sanger sequencing is all the machinery and equipment used in the creation and implementation of Sanger sequencing as well as all the chemicals, reagents, and consumables which are associated with Sanger sequencing. A key step in genomics and associated diagnostics, Sanger sequencing is used in several branches of application, including in personalised medicine, genetic diagnostics\/phylogenetic, and biotechnology to buttress agriculture.<\/p>\n","protected":false},"featured_media":21586,"template":"","meta":{"_acf_changed":false},"product_brand":[],"product_cat":[194],"product_tag":[],"class_list":["post-27198","product","type-product","status-publish","has-post-thumbnail","product_cat-healthcare-life-sciences","first","instock","virtual","purchasable","product-type-simple"],"acf":[],"yoast_head":"\n